Quantcast

Latest Macular degeneration Stories

2014-10-08 08:27:39

HUNTINGTON, N.Y., Oct. 8, 2014 /PRNewswire/ -- For the millions of American adults seeking to effectively support their eye health, there's now yet another reason to take VisiVite(®) AREDS2 PLUS+ Gold: This research-backed macular degeneration formula has now been shown to exhibit 99.8% tolerability. http://photos.prnewswire.com/prnvar/20141008/150947 Dr. Paul Krawitz, President and Founder of VisiVite's parent company, Vitamin Science, Inc., is pleased to acknowledge the notable...

2014-10-08 08:26:24

-- Fourth indication for injection treatment that can stabilize and improve vision(1) -- mCNV a leading cause of visual impairment among those 20-50 years of age(9) Since its launch in Canada in 2007, Lucentis(®) has treated more than 100,000 eyes across all approved indications(3 ) DORVAL, QC, Oct. 8, 2014 /CNW/ - Novartis Pharmaceuticals Canada Inc. announced today that Lucentis(®) (ranibizumab), the treatment for several major causes of vision loss, has been...

2014-10-06 16:27:54

EYLEA Now Approved for Wet Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and Macular Edema following RVO TARRYTOWN, N.Y., Oct. 6, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA(®) (aflibercept) Injection for the treatment of Macular Edema following Retinal Vein Occlusion (RVO), which includes Macular Edema following Branch Retinal Vein Occlusion (BRVO) in addition...

2014-09-30 08:33:35

SAN DIEGO, Sept. 30, 2014 /PRNewswire/ -- While drinking too much alcohol is known to cause vision impairment, studies have shown that drinking red wine can have a positive effect on one's vision by helping to prevent eyesight from deteriorating. Researchers at the Washington University School of Medicine in St. Louis found that resveratrol, a common substance typically found in high levels in grape skins (and therefore red wine), can stop the growth of harmful blood vessels and protect the...

2014-09-25 08:28:34

Vast majority of adults are not getting enough of two nutrients crucial for vision PARSIPPANY, N.J., Sept. 25, 2014 /PRNewswire/ -- A recent survey conducted by DSM Nutritional Products found that 83 percent of adults in the U.S. believe worsening eye health is inevitable with age. What many people don't realize is that there's a connection between healthy eyes and proper nutrition, and it goes beyond eating carrots. To view the multimedia assets associated with this release, please click...

2014-09-22 12:28:34

NEW YORK, September 22, 2014 /PRNewswire/ -- Persistence Market Research (http://www.persistencemarketresearch.com) Released New Market Report on "Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020," the global ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1 million in 2020. Browse the full Global Market Study on...

2014-09-22 04:21:43

TARRYTOWN, N.Y., Sept. 22, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for EYLEA(®) (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV). EYLEA has already been approved in Japan for the treatment of patients with neovascular age-related macular degeneration (wet AMD), and...

2014-09-18 12:29:19

Fovista and Abicipar Pegol Will Need to be Priced Competitively to Current Agents to Garner Favorable Tier Placement, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that Regeneron's Eylea, the most recently launched anti-vascular endothelial growth factor (VEGF) agent for wet AMD, is equally likely to be covered on commercial and Medicare Advantage plans as Genentech's Lucentis, which is the standard of care...

2014-09-16 08:31:22

ST. LOUIS, Sept. 16, 2014 /PRNewswire/ -- According to the American Academy of Ophthalmology, September is Healthy Aging Month. EyePromise has developed free learning resources to celebrate the month that is intended to focus national attention on the positive aspects of growing older and encourage people to take control of their health. Photo - http://photos.prnewswire.com/prnh/20140916/146305 Logo - http://photos.prnewswire.com/prnh/20140916/146306 Learning resources can be found...

2014-09-12 12:25:28

Laser Approved for Treatment of PCV, CSR CLERMONT-FERRAND, France, Sept. 12, 2014 /PRNewswire/ -- Quantel Medical today announced CE Mark approval for its Vitra(TM) PDT photodynamic therapy laser platform, for the treatment of polypoidal choroidal vasculopathy (PCV) and central serous retinopathy (CSR). Quantel, the sole manufacturer of this laser technology, plans to begin commercializing the laser platform immediately in countries requiring CE registration. PCV, a disease of the...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related